These results indicated that CRYAB was a molecule in tumor cells that might be induced by M2 macrophages; in addition, downregulated CRYAB might decrease EMT and the related ERK1/2/Fra-1/slug signaling pathway in lung cancer. This evidence concerns the gene CRYAB and lung carcinoma.